人类囊胚自发性塌陷作为预后标志物:系统综述与荟萃分析
该系统综述与荟萃分析纳入7项回顾性队列研究,评估人类囊胚自发性塌陷(SC)对整倍体率及妊娠结局的预后价值。SC发生率为37.0%(2516/6801),SC与临床妊娠率(RR=0.77,95%CI=0.62-0.95)、持续妊娠率(RR=0.66,95%CI=0.53-0.83)及整倍体率(RR=0.70,95%CI=0.59-0.83)降低显著相关,活产率与流产率无显著差异。
要点
- 囊胚自发性塌陷与整倍体率、临床妊娠率和持续妊娠率降低显著相关。
- 活产率(RR=0.76,95%CI=0.55-1.04)与流产率(RR=1.31,95%CI=0.95-1.80)在塌陷与否组间无显著差异。
- 作者建议在选择宫内移植胚胎时对发生自发性塌陷的囊胚给予低 ranking。
核心结论
- 人类囊胚自发性塌陷与整倍体胚胎率和妊娠率降低相关。
- 作者认为囊胚自发性塌陷对妊娠有负面影响,在选择宫内移植胚胎时应给予低 ranking,并可作为预测妊娠或活产的囊胚算法中的一个变量。
研究设计与样本
- 系统综述与荟萃分析,遵循PRISMA指南,方案注册于PROSPERO(CRD42022373749)。
- 于2022年10月10日检索MEDLINE、EMBASE和Cochrane Library,最终纳入7项回顾性队列研究进行荟萃分析。
主要发现
- 7项研究中囊胚自发性塌陷的发生率为37.0%(2516/6801),范围17.4%至56.2%。
- 自发性塌陷与临床妊娠率显著降低相关(2项研究,n=736;RR=0.77,95%CI=0.62-0.95;I²=30%)。
- 自发性塌陷与持续妊娠率显著降低相关(5项研究,n=2503;RR=0.66,95%CI=0.53-0.83;I²=60%)。
- 自发性塌陷与整倍体率显著降低相关(3项研究,n=3569;RR=0.70,95%CI=0.59-0.83;I²=69%)。
- 活产率(2项研究,n=816;RR=0.76,95%CI=0.55-1.04;I²=56%)和流产率(4项研究,n=1358;RR=1.31,95%CI=0.95-1.80;I²=0%)在有无自发性塌陷的囊胚间无显著差异。
关键数值与推荐
- 持续妊娠率评估的研究间异质性显著(I²=60%,P=0.04)。
- 活产率评估的研究间异质性(I²=56%,P=0.13)。
- 整倍体率评估的研究间异质性显著(I²=69%,P=0.04)。
- 亚组分析按自发性塌陷定义、塌陷事件次数及移植囊胚是否行PGT-A进行,各亚组结果不一致。
临床怎么用
- 作者建议在选择宫内移植胚胎时对发生自发性塌陷的囊胚给予低 ranking。
- 作者建议在构建预测妊娠或活产的囊胚算法时,将囊胚自发性塌陷作为一个变量考虑。
局限性
- 荟萃分析中所有研究均为回顾性研究,不同结局的异质性程度不一。
- 并非所有研究都校正了潜在混杂因素,因此主荟萃分析仅能使用未校正数据。
- 各研究对囊胚自发性塌陷的定义策略略有不同,需要标准化定义以提高未来研究间的可比性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is spontaneous collapse (SC) by human blastocysts a prognostic factor in IVF treatment? SUMMARY ANSWER: SC in human blastocyst is associated with reduced euploid embryo and pregnancy rates. WHAT IS KNOWN ALREADY: SC of the human blastocyst is a phenomenon that was revealed relatively recently following the clinical application of time-lapse monitoring in IVF laboratories. The ploidy and clinical prognosis of affected blastocysts are still poorly understood, with inconsistent reports. Systematic reviews and meta-analyses on this topic are currently absent in the literature but its potential as a marker of embryo viability holds great clinical value. In this study, we aimed to comprehensively evaluate the potential of SC as a prognostic factor in regard to ploidy status, and pregnancy, live birth and miscarriage rates. STUDY DESIGN, SIZE, DURATION: A systematic review and meta-analysis were performed according to PRISMA guidelines, with a protocol registered with PROSPERO (CRD42022373749). A search of MEDLINE, EMBASE, and the Cochrane Library for relevant studies was carried out on 10 October 2022, using key words relevant to 'blastocyst collapse' and 'time-lapse imaging'. PARTICIPANTS/MATERIALS, SETTING, METHODS: Two independent reviewers systematically screened and evaluated each study in terms of participants, exposure, comparator, and outcomes (PECO). The Quality In Prognosis Studies tool was used for quality assessment. Data were extracted according to Cochrane methods. Pregnancy, live birth, ploidy, or miscarriage data were summarized by risk ratios (RRs) or odds ratios and their 95% CIs. All meta-analyses were performed with random-effects models. MAIN RESULTS AND THE ROLE OF CHANCE: Following removal of duplicates, a total of 196 records were identified by the initial search. After screening according to PECO, 19 articles were included for further eligibility assessment. For meta-analysis, seven retrospective cohort studies were eventually included. After data pooling, the incidence of blastocyst SC was 37.0% (2516/6801) among seven studies (ranging from 17.4% to 56.2%). SC was associated with significantly lower clinical pregnancy rates (two studies, n = 736; RR = 0.77, 95% CI = 0.62-0.95; I2 = 30%), ongoing pregnancy rates (five studies, n = 2503; RR = 0.66, 95% CI = 0.53-0.83; I2 = 60%), and reduced euploidy rates (three studies, n = 3569; RR = 0.70, 95% CI = 0.59-0.83; I2 = 69%). Nevertheless, live birth rates (two studies, n = 816; RR = 0.76, 95% CI = 0.55-1.04; I2 = 56%) and miscarriage rate (four studies, n = 1358; RR = 1.31, 95% CI = 0.95-1.80; I2 = 0%) did not differ between blastocysts with or without SC. There was, however, significant heterogeneity between the studies included for evaluation of ongoing pregnancy rates (I2 = 60%, P = 0.04), live birth rates (I2 = 56%, P = 0.13), and ploidy rates (I2 = 69%, P = 0.04). Subgroup analyses were conducted according to different definitions of SC, number of collapse events, and whether the transferred blastocyst had undergone preimplantation genetic testing for aneuploidy; with inconclusive findings across subgroups. LIMITATIONS, REASONS FOR CAUTION: All studies in the meta-analysis were retrospective with varying levels of heterogeneity for different outcomes. Not all studies had accounted for potential confounding factors, therefore only unadjusted data could be used in the main meta-analysis. Studies employed slightly different strategies when defining blastocyst SC. Standardization in the definition for SC is needed to improve comparability between future studies. WIDER IMPLICATIONS OF THE FINDINGS: Our results indicate that blastocyst SC has negative implications for a pregnancy. Such blastocysts should be given a low ranking when selecting from a cohort for intrauterine transfer. Blastocyst SC should be considered as a contributing variable when building blastocyst algorithms to predict pregnancy or live birth. STUDY FUNDING/COMPETING INTEREST(S): There is no external funding to report. All authors report no conflict of interest. REGISTRATION NUMBER: PROSPERO 2022 CRD42022373749.
引用
- Bickendorf K, Qi F, Peirce K, et al. Spontaneous collapse as a prognostic marker for human blastocysts: a systematic review and meta-analysis. Hum Reprod. 2023. PMID: 37581900. doi:10.1093/humrep/dead166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。